Creon DR 24,000 unit capsule UU 100S
Ended Awarded
- Contract number
- SPE2DR26F4Q4Y
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,452
Award facts
- Contract value 100% obligated
- $2,452.27 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $2,452.27 delivery order to Amerisourcebergen Drug Corp on July 14, 2026, for 24,000 unit capsules of Creon (pancreatic enzyme replacement therapy).
Place of performance is Conshohocken, PA. The order has a firm fixed-price structure with an ultimate completion date of July 15, 2026. No set-aside was applied.
Quick answers
Who was awarded contract SPE2DR26F4Q4Y?
SPE2DR26F4Q4Y was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 14, 2026.
How much is contract SPE2DR26F4Q4Y worth?
The government has obligated $2,452 on SPE2DR26F4Q4Y.
Is contract SPE2DR26F4Q4Y an order under another contract?
Yes. SPE2DR26F4Q4Y is a delivery order under SPE2DR25D3012, an indefinite delivery contract.
Was contract SPE2DR26F4Q4Y competed?
The extent of competition for SPE2DR26F4Q4Y was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award